Formaldehyde Found in GMO Soybeans R
esearchers from the International Center for Integra- tive Systems, in Cambridge, Massachusetts, have determined that genetically modified (GM/GMO) soy- bean plants accumulate the carcinogen formaldehyde. The researchers utilized a scientific method called
CytoSolve to analyze 6,497 diverse laboratory studies conducted by 184 scientific institutions in 23 countries worldwide. The study data showed that GMO soybeans significantly accumulate formaldehyde, a class-one carcinogen. The research also found that genetic modification forces a depletion of gluta- thione among the plants, which weakens their immune system. This contrasts with the proposals put forth by the GM industry that GMO soybean plants are stronger, allowing them to endure environmental hardships better than non-GMO soybean plants. The research was led by V.A. Shiva Ayyadurai, Ph.D., a biologist trained at the
Massachusetts Institute of Technology, and published in the peer-reviewed journal Agricultural Sciences. “The results demand immediate testing, along with rigorous scientific standards to assure such testing is objective and replicable. It’s unbeliev- able such standards for testing don’t already exist. The safety of our food supply demands that science delivers such modern scientific standards for approval of GMOs,” states Ayyadurai. Former Environmental Protection Agency Senior Scientist Ray Seidler, Ph.D., comments about the study, “The discovery reported by Ayyadurai reveals a new molecular paradigm associated with genetic engineering that will require research to discover why the extent of formaldehyde and glutathione concentrations are altered, and what other chemicals relevant to human and animal health are affected. We need the kinds of standards Ayyadurai demands to conduct such research.”
Antidepressants in Pregnancy Raises Risk of Hypertension in Kids I
n a large study published in the Journal of the American Medical Association, researchers from participating univer- sities found mothers that take antidepressant drugs during pregnancy face the risk of heart issues for their children. The researchers tested 3,789,330 pregnant women between 2000 and 2010. Of these, 128,950 took at least one prescription for antidepressants during their pregnan- cy. High blood pressure among children of mothers that didn’t take antidepressants was about 21 percent. Children that were exposed to selective serotonin reuptake inhibitor (SSRI) antidepressant drugs during pregnancy experienced high blood pressure in 31.5 percent of the cases. Those that were exposed to non-SSRI antidepressants experienced high blood pressure 29 percent of the time.
This represents a 50 percent increased risk of hypertension for babies of moth- ers that take SSRIs during pregnancy and a 40 percent increased risk for children exposed to non-SSRIs.
In their conclusion, the researchers note, “Evidence from publicly insured
pregnant women studied may be consistent with a potential increased risk of persistent pulmonary hypertension of the newborn associated with maternal use of selective serotonin reuptake inhibitors in late pregnancy.”
Watch it Light Up the Season
Advertise in our special December Prayer and Meditation Issue
To advertise or
participate in our next issue, call
763-270-8604 natural awakenings November 2015 9
Rekindle the Spirit of Your Life
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32